Effects of dehydroepiandrosterone sulfate on anxiety and depressive behavior: Involvement of μ-opioid receptors

Neuroscience and Behavioral Physiology

Volumn 43, Issue 4, 2013, Pages 505-511

  Ovsyukova, M V ^a   Obut, T A ^a   Saryg, S K ^a  

^a INSTITUTE OF PHYSIOLOGY   (Russian Federation)

Author keywords

Anxiety; Dehydroepiandrosterone sulfate; Depression; Stress; opioid receptors

Indexed keywords

MU OPIATE RECEPTOR; NALTREXONE; PRASTERONE SULFATE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ANXIETY; ARTICLE; CHRONIC STRESS; DEPRESSION; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; DRUG SELECTIVITY; MALE; MAZE TEST; MOTOR ACTIVITY; MOUSE; NONHUMAN; PHARMACOLOGICAL BLOCKING; RAT; SINGLE DRUG DOSE; TRANQUILIZING ACTIVITY;

EID: 84902309858     PISSN: 00970549     EISSN: 1573899X     Source Type: Journal    
DOI: 10.1007/s11055-013-9763-7     Document Type: Article

References (29)

1. D. F. Avgustinovich, T. V. Lipina, O. V. Alekseenko, et al., "Characteristics of the functional activity of the brain serotoninergic system in producing natural and pathological anxiety in mice: effects of genotype," Zh. Vyssh. Nerv. Deyat., 48, No. 2, 331-341 (1999).
2. N. N. Kudryavtseva, "Agonistic behavior: model, experiment, perspectives," Ros. Fiziol. Zh. im. I. M. Sechenova, 85, No. 1, 61-83 (1999).
3. N. N. Kudryavtseva, "Use of the 'partition' test in behavioral and pharmacological experiments," Ros. Fiziol. Zh. im. I. M. Sechenova, 88, No. 1, 90-105 102
4. T. A. Obut, M. V. Ovsyukova, and O. P. Cherkasova, "Effects of dehydroepiandrosterone sulfate on stress reactivity: a μ opioid mechanism," Ros. Fiziol. Zh. im. I. M. Sechenova, 88, No. 12, 1578-1584 (2002).
5. P. S. Brocardo, J. Budni, K. R. Lobato, et al., "Evidence for the involvement of the opioid system in the antidepressant-like effect of folic acid in the mouse forced swimming test," Behav. Brain Res., 200, No. 1, 122-127 (2009).
6. P. O. Cover and J. C. Buckingham, "Effects of selective opioid-receptor blockade on the hypothalamo-pituitary-adrenocortical responses to surgical trauma in the rat," J. Endocrinol., 121, No. 2, 213-220 (1989).
7. J. F. Cryan, A. Markou, and I. Lucki, "Assessing antidepressant activity in rodents: recent developments and future needs," Trends Pharmacol. Sci., 23, No. 5, 238-245 (2002).
8. A. Dhir and S. Kulkarni, "Involvement of sigma (sigma1) receptors in modulating the anti-depressant effect of neurosteroids (dehydroepiandrosterone or pregnenolone) in mouse tail-suspension test," J. Psychopharmacol., 22, No. 6, 691-696 (2008).
9. R. S. Duman, "Neuronal damage and protection in the pathophysiology and treatment of psychiatric illness: stress and depression," Dialog. Clin. Neurosci., 11, No. 3, 239-255 (2009).
10. R. Genud, A. Merenlender, I. Gispam-Herman, et al., "DHEA lessens depressive-like behavior via GABA-ergic modulation of the mesolimbic system," Neuropsychopharmacology, 34, No. 3, 577-584 (2009).
11. A. Gregus, A. J. Wintink, A. C. Davis, and L. E. Kalynchuk, "Effect of repeated corticosterone injections and restraint stress on anxiety and depression-like behavior in male rats," Behav. Brain Res., 156, No. 1, 105-114 (2005).
12. M. Inagaki, A. Kagaya, M. Takebayashi, et al., "Effect of acute and chronic administration of dehydroepiandrosterone on (+/-)-1-(2,5-dimethoxy-4- iodophenyl)-2-aminopropane-induced wet dog shaking behavior in rats," J. Neural Transm., 106, No. 1, 23-33 (1999).
13. G. Juhàsz-Vedres, E. Rózsa, G. Rákos, et al., "Dehydroepiandrosterone sulfate is neuroprotective when administered either before or after injury in a focal cortical cold lesion model," Endocrinology, 147, No. 2, 683-686 (2006).
14. A. Keeney, D. S. Jessop, M. S. Harbuz, et al., "Differential effects of acute and chronic social defeat stress on hypothalamic-pituitary-adrenal axis function and hippocampal serotonin release in mice," J. Neuroendocrinol., 18, No. 5, 330-338 (2006).
15. R. Maayan, D. Touati-Werner, E. Ram, et al., "The protective effect of frontal cortex dehydroepiandrosterone in anxiety and depressive models in mice," Pharmacol. Biochem. Behav., 85, No. 2, 415-421 (2006).
16. N. Maninger, O. M. Wolkowitz, V. I. Reus, et al., "Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS)," Front. Neuroendocrinol., 30, No. 1, 65-91 (2009).
17. K. Markopooulou, A. Papadopoulos, M. F. Juruena, et al., Psychoneuroendocrinology, 34, No. 1, 19-26 (2009).
18. G. Naert, T. Maurice, L. Tapia-Arancibia, and L. Givalois, "Neuroactive steroids modulate HPA axis activity and cerebral brain-derived neurotrophic factor (BDNF) protein levels in adult male rats," Psychoneuroendocrinology, 32, No. 8-10, 1062-1078 (2007).
19. I. Pérez-Neri, S. Montes, C. Ojeda-López, et al., "Modulation of neurotransmitter systems by dehydroepiandrosterone and dehydroepiandrosterone sulfate: mechanism of action and relevance to psychiatric disorders," Prog. Neuropsychopharmacol. Biol. Psychiatry, 32, No. 5, 1118-1130 (2008).
20. R. D. Porsolt, G. Anton, N. Blavet, and M. Jalfre, "Behavioural despair in rats: a new model sensitive to antidepressant treatments." Eur. J. Pharmacol., 47, No. 4, 379-391 (1978).
21. A. Prasad, M. Imamura, and C. Prasad, "Dehydroepiandrosterone decreases behavioral despair in high- but not low-anxiety rats," Physiol. Behav., 62, No. 5, 1053-1057 (1997).
22. P. Rada, S. A. Moreno, S. Tucci, et al., "Glutamate release in the nucleus accumbens is involved in behavioral depression during the Porsolt swim test," Neurosci., 119, 557-565 (2003).
23. 1) receptor mediated antidepressant-like effects of neurosteroids in the Porsolt forced swim test," Neuroreport, 9, 3069-3073 (1998).
24. R. J. Rodgers and J. C. Cole, "The elevated plus-maze: pharmacology, methodology and ethology," in: Ethology and Psychopharmacology, S. J. Cooper and C. A. Hendrie (eds.), Wiley, Chichester (1994), pp. 9-44.
25. M. A. Steiner, G. Marsicano, E. J. Nestler, et al., "Antidepressant- like behavioral effects of impaired cannabinoid receptor type 1 signaling coincide with exaggerated corticosterone secretion in mice," Psychoneuroendocrinology, 33, No. 1, 54-67 (2008).
26. P. L. Tenore, "Psychotherapeutic benefits of opioid agonist therapy," J. Addict. Dis., 27, No. 3, 49-65 (2008).
27. A. L. Vaccarino, G. A. Olson, R. D. Olson, and A. J. Kastin, "Endogenous opiate: 1998," Peptides, 20, 1527-1574 (1999).
28. H. M. Van Praag, "Can stress cause depression?" World J. Biol. Psychiatry, 6, No. 2, 5-22 (2005).
29. O. M. Wolkowitz, V. I. Reus, E. Roberts, et al., " Dehydroepiandrosterone (DHEA) treatment of depression," Biol. Psychiatry, 41, 311-318 (1997).